ACT Oncology is a full-service clinical research organization (CRO) specializing in providing outstanding, cost-effective and responsive oncology drug development support for biotech, pharmaceutical and non-profit oncology organizations. Our team of clinical research experts is dedicated to supporting our Sponsors’ Phase I-III oncology programs, registries and Investigator Sponsored Trials.

Founded by Patricia Devitt Risse, Pharm.D. in 2000, and certified as a Women Business Enterprise by the State of New Jersey, the company has grown from a specialized group of oncology and CRO experts to a robust team providing North American and International support to a diverse client base of leading biotech, pharmaceutical and non-profit oncology organizations. Each team member at ACT Oncology is recruited based on their expertise in oncology drug development. We have been remarkably successful at attracting and retaining outstanding personnel who share a common passion for oncology research and a commitment to client service.

Our Project Management staff has an average of 18 years of industry experience and our negligible turnover rate of less than 2 percent since the company’s inception ensures that this wealth of experience is available to our Sponsors.

We place great emphasis on ensuring clear communication and on developing creative solutions to operational challenges. Our organizational structure is designed to optimize support of our project teams and to ensure that Sponsors receive flexible, responsive and cost-effective services.